Send feedback

BRAF p.Ile208Val

c.622A>G · rs727504571 · VCV178963

Uncertain significance Expert panel
Classification
Uncertain significance
ClinVar
Review
Expert panel ★★★☆
ClinVar · 6 submitters
AlphaMissense
likely benign
0.0918 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00267%, afr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
RASopathy

ClinGen expert panel — RASopathy VCEP

Likely Benign for RASopathy. Applied ACMG criteria (verbatim):

PP2 BS2

Curation rationale (ClinGen, verbatim)

The c.622A>G (p.Ile208Val) variant in BRAF is present in 0.00001% (2/128934) European alleles in gnomAD. The computational predictor REVEL gives a score of 0.318, which is neither above nor below the thresholds predicting a damaging or benign impact on BRAF function. This variant was observed in two healthy adult individuals who did not have clinical features of a RASopathy (SCV000205449.5; PMID:29945942). Additionally, 12 apparently unaffected parental samples were observed with this variant (BS2; SCV000329576.8, SCV001011557.1). The variant is located in the BRAF gene, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic missense variants are common (PP2; PMID: 29493581). In summary, this variant meets the criteria to be classified as likely benign for autosomal dominant RASopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BS2, PP2 (RASopathy VCEP specifications version 1; 8/11/22).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.0918likely benign
REVEL0.318indeterminate
SaProtLLR -7.13tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.8GERP 2.5, phastCons 1
Overall
CADD24.6PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00267% African / African-American · 2/74,860 alleles
Filtering AF 0.00114% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000972%
Overall 0.00149% 24/1,612,526 alleles · very rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.00267% 37,430
European (non-Finnish) 0.00178% 56,134
South Asian 0.0011% 91,040

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BRAF
Protein
p.Ile208Val
Coding
c.622A>G
MANE Select
NM_004333
dbSNP
rs727504571
Type
single nucleotide variant
Location
chr7:140808049 (GRCh38)
Gene constraint
LOEUF 0.237 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 67.87 · 135 PDB
Residue 208
a β-strand; the rbd domain
Full BRAF gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/braf-p-ile208val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown